Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_provenance.
- NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_assertion description "[Thus, targeting multiple metabolic stress pathways including the LKB1/AMPK pathway enhances lovastatin's ability to synergize with gefitinib in SCC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_provenance.
- NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_assertion evidence source_evidence_literature NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_provenance.
- NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_assertion SIO_000772 23029387 NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_provenance.
- NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_assertion wasDerivedFrom befree-2016 NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_provenance.
- NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_assertion wasGeneratedBy ECO_0000203 NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_provenance.